n acetylcysteine in recurrent uti

Reading File

Searching PubMed

N-acetylcysteine urinary tract infection recurrent

Reading Article

PMID: 37630763

Reading Article

PMID: 34438950

Finding Sources

Searching PubMed

N-acetylcysteine biofilm urinary catheter

Reading Article

PMID: 37965267

Reading Article

PMID: 40726828

Searching PubMed

N-acetylcysteine recurrent cystitis clinical trial prevention

Searching PubMed

acetylcysteine D-mannose hyaluronic acid UTI prevention combination

Searching the Web

N-acetylcysteine recurrent UTI clinical evidence mechanism 2023 2024

Here is a thorough synthesis of the current evidence on NAC in recurrent UTI:

N-Acetylcysteine (NAC) in Recurrent UTI

Mechanisms of Action

NAC works through several distinct pathways relevant to recurrent UTI:

1. Anti-biofilm activity NAC disrupts biofilm structure by cleaving disulfide bonds in the extracellular polymeric matrix that holds biofilms together. In vitro studies show it inhibits biofilm formation by E. coli, E. faecalis, and Pseudomonas aeruginosa, and significantly reduces viable bacteria in established 48-hour biofilms - especially when combined with ciprofloxacin [PMID: 34438950, Manoharan et al., Antibiotics 2021; PMID: 40726828, Manoharan et al., Biofilm 2025].

2. Prevention of intracellular bacterial communities (IBCs) A key driver of recurrent UTI is uropathogenic E. coli (UPEC) invading bladder epithelial cells (BECs) and forming quiescent intracellular reservoirs that survive antibiotic courses. NAC was shown to completely inhibit BEC invasion by multiple E. coli and E. faecalis clinical strains in a dose-dependent manner (p < 0.01), with >90% cellular viability maintained - meaning NAC is not cytotoxic to bladder cells despite its low pH [PMID: 34438950].

3. Urease inhibition (especially for CA-UTIs) Proteus mirabilis, a common cause of catheter-associated UTI (CA-UTI), produces urease that alkalinizes urine, precipitates struvite crystals, and blocks catheters. NAC inhibits P. mirabilis urease at concentrations as low as 1 mM, preventing crystalline biofilm formation and catheter occlusion. It also reduces IL-6, IL-8, and IL-1β production in BECs exposed to P. mirabilis - a dual antibiofilm + anti-inflammatory effect [PMID: 37965267, Manoharan et al., Front Cell Infect Microbiol 2023].

4. Antioxidant / mucosal protective effect As a glutathione precursor, NAC reduces oxidative stress in the urothelium during infection, potentially limiting inflammatory epithelial damage that facilitates re-infection.

Combination Approaches

NAC is increasingly studied as part of multi-ingredient oral formulations, often combined with:

D-mannose (blocks FimH-mediated E. coli adhesion to uroepithelium)
Hyaluronic acid / chondroitin sulphate (glycosaminoglycan layer replenishment)

A 2023 narrative review ([PMID: 37630763], Crocetto et al., Nutrients) summarized the complementary mechanisms: D-mannose targets bacterial adhesion, hyaluronic acid restores the protective GAG layer, and NAC dismantles biofilms - making the combination theoretically synergistic. Clinical data on these combinations remain limited to small studies and one 2017 Italian trial (Palleschi et al.) showing D-mannose + probiotic + NAC was comparable to 7-day antibiotics for preventing recurrence in post-urodynamic UTI.

Clinical Evidence Summary

Level	Evidence
In vitro	Strong - inhibits invasion, biofilm, urease across multiple uropathogens
Animal/model	Positive - catheter bladder models show 4-8 log reduction in viable bacteria
Clinical RCT	Very limited - no large, dedicated RCT on NAC monotherapy for recurrent UTI
Guidelines	Not included in AUA 2024 rUTI guidelines; not in standard prophylaxis recommendations

The AUA 2024 recurrent UTI guideline (updated through November 2024) does not mention NAC as a recommended intervention. Current non-antibiotic prophylaxis options with better evidence include vaginal estrogens, D-mannose, methenamine hippurate, and cranberry.

Practical Considerations

Dose used in most studies: 600 mg orally 2-3x daily (though no consensus clinical dose for UTI exists)
Safety: Well-established safety profile; NAC is non-toxic to bladder epithelium in vitro
Resistance: Does not contribute to antibiotic resistance - a meaningful advantage given rising fluoroquinolone/TMP-SMX resistance
Who may benefit most: Patients with catheter-associated or biofilm-driven recurrent UTI, or those where standard antibiotic prophylaxis has failed or is contraindicated
Commercially available as: Uroial PLUS (NAC + D-mannose + hyaluronic acid + chondroitin), marketed in Italy/Europe for UTI prevention

Bottom Line

NAC has mechanistically compelling preclinical data for recurrent UTI - particularly against IBC formation, polymicrobial biofilms, and CA-UTI due to Proteus. However, high-quality clinical trials (RCTs) evaluating NAC specifically for recurrent UTI prevention are lacking as of mid-2026. It is best considered an adjunct or add-on to standard prophylaxis strategies rather than a standalone first-line agent, and is most promising in biofilm-driven or catheter-associated recurrence patterns.

Create a clinical summary or quick reference PDF on NAC mechanisms and dosing

Reading File

Running Command

ls -la /home/daytona/workspace/ 2>/dev/null || echo "workspace empty or not found"

Running Command

mkdir -p /home/daytona/workspace/nac-uti-pdf

Writing File

~/nac-uti-pdf/generate_pdf.py

from reportlab.lib.pagesizes import A4
from reportlab.lib import colors
from reportlab.lib.styles import getSampleStyleSheet, ParagraphStyle
from reportlab.lib.units import mm, cm
from reportlab.platypus import (
    SimpleDocTemplate, Paragraph, Spacer, Table, TableStyle,
    HRFlowable, KeepTogether
)
from reportlab.lib.enums import TA_LEFT, TA_CENTER, TA_JUSTIFY
from reportlab.platypus import BaseDocTemplate, Frame, PageTemplate
from reportlab.lib.colors import HexColor

OUTPUT = "/home/daytona/workspace/nac-uti-pdf/NAC_in_Recurrent_UTI_Clinical_Reference.pdf"

# --- Color palette ---
DARK_BLUE   = HexColor("#1A3A5C")
MED_BLUE    = HexColor("#2563A8")
LIGHT_BLUE  = HexColor("#D6E4F7")
ACCENT      = HexColor("#0E7A6E")   # teal for secondary headers
ACCENT_LIGHT= HexColor("#D0F0EC")
ORANGE      = HexColor("#C0522B")
ORANGE_LIGHT= HexColor("#FAE5DA")
GREY_BG     = HexColor("#F4F6F9")
GREY_LINE   = HexColor("#C8D0DB")
WHITE       = colors.white
BLACK       = colors.black

W, H = A4  # 595.27 x 841.89 pts

# --- Page drawing callbacks ---
def draw_header(canvas, doc):
    canvas.saveState()
    # Top banner
    canvas.setFillColor(DARK_BLUE)
    canvas.rect(0, H - 52, W, 52, fill=1, stroke=0)
    canvas.setFillColor(WHITE)
    canvas.setFont("Helvetica-Bold", 17)
    canvas.drawString(20, H - 28, "N-Acetylcysteine (NAC) in Recurrent UTI")
    canvas.setFont("Helvetica", 9)
    canvas.drawString(20, H - 43, "Clinical Quick Reference  |  Mechanisms, Dosing & Evidence")

    # Right badge
    canvas.setFillColor(ACCENT)
    canvas.roundRect(W - 110, H - 48, 98, 36, 6, fill=1, stroke=0)
    canvas.setFillColor(WHITE)
    canvas.setFont("Helvetica-Bold", 8)
    canvas.drawCentredString(W - 61, H - 30, "UROLOGY / ID")
    canvas.setFont("Helvetica", 7)
    canvas.drawCentredString(W - 61, H - 41, "Quick Reference Card")

    # Footer
    canvas.setFillColor(GREY_LINE)
    canvas.rect(0, 0, W, 22, fill=1, stroke=0)
    canvas.setFillColor(DARK_BLUE)
    canvas.setFont("Helvetica", 7.5)
    canvas.drawString(20, 7, "For clinical guidance only. Not a substitute for professional judgment. Sources: Manoharan et al. 2021/2023/2025; Crocetto et al. 2023.")
    canvas.drawRightString(W - 20, 7, f"Page {doc.page}")
    canvas.restoreState()

def draw_first_page(canvas, doc):
    draw_header(canvas, doc)

# --- Document setup ---
doc = BaseDocTemplate(
    OUTPUT,
    pagesize=A4,
    leftMargin=18*mm, rightMargin=18*mm,
    topMargin=60, bottomMargin=30,
    title="NAC in Recurrent UTI - Clinical Quick Reference",
    author="Orris Clinical Reference"
)
frame = Frame(doc.leftMargin, doc.bottomMargin,
              doc.width, doc.height, id='normal')
doc.addPageTemplates([
    PageTemplate(id='all', frames=frame, onPage=draw_header)
])

# --- Styles ---
styles = getSampleStyleSheet()

def S(name, **kwargs):
    return ParagraphStyle(name, **kwargs)

body = S("body", fontSize=9, leading=13, textColor=BLACK, spaceAfter=4,
         fontName="Helvetica")
body_j = S("body_j", fontSize=9, leading=13, textColor=BLACK, spaceAfter=4,
           fontName="Helvetica", alignment=TA_JUSTIFY)
bold_body = S("bold_body", fontSize=9, leading=13, textColor=BLACK, spaceAfter=3,
              fontName="Helvetica-Bold")
section_hdr = S("sec_hdr", fontSize=11, leading=14, textColor=WHITE,
                fontName="Helvetica-Bold", alignment=TA_LEFT,
                backColor=DARK_BLUE, spaceBefore=8, spaceAfter=0,
                leftIndent=0)
sub_hdr = S("sub_hdr", fontSize=9.5, leading=12, textColor=DARK_BLUE,
            fontName="Helvetica-Bold", spaceBefore=5, spaceAfter=2)
bullet = S("bullet", fontSize=9, leading=13, textColor=BLACK,
           fontName="Helvetica", leftIndent=12, bulletIndent=2,
           spaceAfter=2)
small = S("small", fontSize=7.5, leading=10, textColor=HexColor("#555555"),
          fontName="Helvetica", spaceAfter=2)
note = S("note", fontSize=8, leading=11, textColor=HexColor("#333333"),
         fontName="Helvetica-Oblique", spaceAfter=3)
warn = S("warn", fontSize=8.5, leading=12, textColor=ORANGE,
         fontName="Helvetica-Bold", spaceAfter=3)

def section_title(text, bg=DARK_BLUE, fg=WHITE):
    tbl = Table([[Paragraph(f"  {text}", S("sh", fontSize=10.5,
                  fontName="Helvetica-Bold", textColor=fg, leading=14))]],
                colWidths=[doc.width])
    tbl.setStyle(TableStyle([
        ("BACKGROUND", (0,0), (-1,-1), bg),
        ("TOPPADDING",  (0,0), (-1,-1), 5),
        ("BOTTOMPADDING", (0,0), (-1,-1), 5),
        ("LEFTPADDING",  (0,0), (-1,-1), 8),
        ("RIGHTPADDING", (0,0), (-1,-1), 8),
        ("ROUNDEDCORNERS", [4]),
    ]))
    return tbl

def accent_section(text):
    return section_title(text, bg=ACCENT, fg=WHITE)

def orange_section(text):
    return section_title(text, bg=ORANGE, fg=WHITE)

def info_box(paragraphs, bg=LIGHT_BLUE, border=MED_BLUE):
    inner = [[p] for p in paragraphs]
    flat  = [[item] for sublist in [[p] for p in paragraphs] for item in [sublist[0]]]
    tbl = Table([[Paragraph(p.text if hasattr(p,'text') else '', p) 
                  if not isinstance(p, str) else Paragraph(p, body) 
                  for _ in [1]] for p in paragraphs],
                colWidths=[doc.width - 16])
    # Use a simpler approach: stack all paras in one cell
    cell_content = paragraphs
    tbl2 = Table([cell_content], colWidths=[doc.width])
    # Actually best: one column, each para in its own row
    rows = [[p] for p in paragraphs]
    tbl3 = Table(rows, colWidths=[doc.width])
    tbl3.setStyle(TableStyle([
        ("BACKGROUND", (0,0), (-1,-1), bg),
        ("LINEAFTER",  (0,0), (0,-1), 3, border),
        ("LINEBEFORE", (0,0), (0,-1), 3, border),
        ("TOPPADDING",  (0,0), (-1,-1), 3),
        ("BOTTOMPADDING", (0,0), (-1,-1), 3),
        ("LEFTPADDING",  (0,0), (-1,-1), 8),
        ("RIGHTPADDING", (0,0), (-1,-1), 8),
    ]))
    return tbl3

# ============================================================
# BUILD CONTENT
# ============================================================
story = []

# ---- INTRO BOX ----
intro_rows = [
    [Paragraph("<b>What is NAC?</b>", S("ib", fontSize=9.5, fontName="Helvetica-Bold",
               textColor=DARK_BLUE, leading=13)),
     Paragraph(
       "N-Acetylcysteine (NAC) is a thiol-containing antioxidant and glutathione precursor. "
       "In the urinary tract it acts as a mucolytic, anti-biofilm, anti-inflammatory, and "
       "anti-invasive agent. It is not an antibiotic, carries no resistance risk, and has a "
       "well-established safety profile.",
       S("ib2", fontSize=9, fontName="Helvetica", textColor=BLACK, leading=13))]
]
intro_tbl = Table(intro_rows, colWidths=[110, doc.width - 110])
intro_tbl.setStyle(TableStyle([
    ("BACKGROUND", (0,0), (-1,-1), LIGHT_BLUE),
    ("VALIGN", (0,0), (-1,-1), "TOP"),
    ("LINEABOVE", (0,0), (-1,0), 2, MED_BLUE),
    ("LINEBELOW", (0,-1), (-1,-1), 2, MED_BLUE),
    ("TOPPADDING",    (0,0), (-1,-1), 6),
    ("BOTTOMPADDING", (0,0), (-1,-1), 6),
    ("LEFTPADDING",   (0,0), (-1,-1), 8),
    ("RIGHTPADDING",  (0,0), (-1,-1), 8),
]))
story.append(intro_tbl)
story.append(Spacer(1, 8))

# ============================================================
# SECTION 1: MECHANISMS
# ============================================================
story.append(section_title("1.  Mechanisms of Action in Recurrent UTI"))
story.append(Spacer(1, 6))

mech_data = [
    # header row
    [
        Paragraph("<b>Mechanism</b>", S("th", fontSize=9, fontName="Helvetica-Bold",
                  textColor=WHITE, leading=12)),
        Paragraph("<b>Detail</b>", S("th2", fontSize=9, fontName="Helvetica-Bold",
                  textColor=WHITE, leading=12)),
        Paragraph("<b>Pathogens / Context</b>", S("th3", fontSize=9, fontName="Helvetica-Bold",
                  textColor=WHITE, leading=12)),
    ],
    [
        Paragraph("<b>Anti-biofilm</b>", S("mc", fontSize=8.5, fontName="Helvetica-Bold",
                  textColor=DARK_BLUE, leading=12)),
        Paragraph(
            "Cleaves disulfide bonds in extracellular polymeric substance (EPS). "
            "Inhibits biofilm formation and reduces viable counts in 48-h preformed biofilms. "
            "Alters bacterial surface structure, impairing initial attachment.",
            S("md", fontSize=8.5, fontName="Helvetica", leading=12)),
        Paragraph("<i>E. coli, E. faecalis, P. aeruginosa, P. mirabilis</i>",
                  S("mp", fontSize=8.5, fontName="Helvetica-Oblique", leading=12)),
    ],
    [
        Paragraph("<b>Prevents Intracellular Bacterial Communities (IBCs)</b>",
                  S("mc2", fontSize=8.5, fontName="Helvetica-Bold", textColor=DARK_BLUE, leading=12)),
        Paragraph(
            "UPEC invades bladder epithelial cells (BECs), forming quiescent reservoirs that "
            "survive antibiotic courses and seed relapse. NAC completely inhibits BEC invasion "
            "by UPEC and E. faecalis in a dose-dependent manner (p<0.01) with no cytotoxicity "
            "to host cells (>90% viability at 48 h).",
            S("md2", fontSize=8.5, fontName="Helvetica", leading=12)),
        Paragraph("Recurrent <i>E. coli</i> UTI (most common cause of rUTI)",
                  S("mp2", fontSize=8.5, fontName="Helvetica-Oblique", leading=12)),
    ],
    [
        Paragraph("<b>Urease inhibition</b>",
                  S("mc3", fontSize=8.5, fontName="Helvetica-Bold", textColor=DARK_BLUE, leading=12)),
        Paragraph(
            "Inhibits P. mirabilis urease at >=1 mM, preventing ammonia-driven urine "
            "alkalinization, struvite crystal formation, and catheter occlusion. Independent "
            "of bactericidal action. Bacteriostatic effect also observed.",
            S("md3", fontSize=8.5, fontName="Helvetica", leading=12)),
        Paragraph("Catheter-associated UTI (CA-UTI); <i>Proteus mirabilis</i>",
                  S("mp3", fontSize=8.5, fontName="Helvetica-Oblique", leading=12)),
    ],
    [
        Paragraph("<b>Anti-inflammatory</b>",
                  S("mc4", fontSize=8.5, fontName="Helvetica-Bold", textColor=DARK_BLUE, leading=12)),
        Paragraph(
            "Reduces IL-6, IL-8, and IL-1beta production in BECs exposed to P. mirabilis "
            "and urease. Antioxidant action via glutathione replenishment limits oxidative "
            "epithelial damage, reducing vulnerability to re-infection.",
            S("md4", fontSize=8.5, fontName="Helvetica", leading=12)),
        Paragraph("Urothelial protection; post-infection recovery",
                  S("mp4", fontSize=8.5, fontName="Helvetica-Oblique", leading=12)),
    ],
    [
        Paragraph("<b>Synergy with antibiotics</b>",
                  S("mc5", fontSize=8.5, fontName="Helvetica-Bold", textColor=DARK_BLUE, leading=12)),
        Paragraph(
            "Combination of NAC + ciprofloxacin significantly reduces bacterial loads in "
            "preformed biofilms beyond either agent alone. Disrupts biofilm matrix, improving "
            "antibiotic penetration.",
            S("md5", fontSize=8.5, fontName="Helvetica", leading=12)),
        Paragraph("Biofilm-mediated recurrent UTI; treatment failure cases",
                  S("mp5", fontSize=8.5, fontName="Helvetica-Oblique", leading=12)),
    ],
]

col_w = [120, doc.width - 120 - 110, 110]
mech_tbl = Table(mech_data, colWidths=col_w, repeatRows=1)
mech_tbl.setStyle(TableStyle([
    ("BACKGROUND",    (0,0), (-1,0), DARK_BLUE),
    ("TEXTCOLOR",     (0,0), (-1,0), WHITE),
    ("BACKGROUND",    (0,1), (-1,1), GREY_BG),
    ("BACKGROUND",    (0,2), (-1,2), WHITE),
    ("BACKGROUND",    (0,3), (-1,3), GREY_BG),
    ("BACKGROUND",    (0,4), (-1,4), WHITE),
    ("BACKGROUND",    (0,5), (-1,5), GREY_BG),
    ("VALIGN",        (0,0), (-1,-1), "TOP"),
    ("GRID",          (0,0), (-1,-1), 0.4, GREY_LINE),
    ("TOPPADDING",    (0,0), (-1,-1), 5),
    ("BOTTOMPADDING", (0,0), (-1,-1), 5),
    ("LEFTPADDING",   (0,0), (-1,-1), 6),
    ("RIGHTPADDING",  (0,0), (-1,-1), 6),
    ("LINEABOVE",     (0,0), (-1,0), 0, DARK_BLUE),
    ("LINEBELOW",     (0,-1), (-1,-1), 1.2, DARK_BLUE),
]))
story.append(mech_tbl)
story.append(Spacer(1, 10))

# ============================================================
# SECTION 2: DOSING
# ============================================================
story.append(section_title("2.  Dosing Guidance"))
story.append(Spacer(1, 6))

# Two-column layout for dosing
dose_left = [
    Paragraph("<b>Oral (systemic) - most studied for UTI:</b>", sub_hdr),
    Paragraph("600 mg <b>2-3 times daily</b> (total 1200-1800 mg/day)", body),
    Paragraph("- Duration: typically 3-6 months for prophylaxis", bullet),
    Paragraph("- Taken with food to reduce GI upset", bullet),
    Paragraph("- No consensus clinical dose specific to UTI; extrapolated from in vitro MIC data and "
              "combination product trials", note),
    Spacer(1, 6),
    Paragraph("<b>Intravesical (investigational):</b>", sub_hdr),
    Paragraph("Used in catheter-flushing protocols in research settings. Not standard of care.", body),
    Spacer(1, 6),
    Paragraph("<b>Combination products (e.g. Uroial PLUS):</b>", sub_hdr),
    Paragraph("NAC 200 mg + D-mannose + hyaluronic acid + chondroitin sulphate", body),
    Paragraph("- 1 sachet once daily for 30-90 days (per manufacturer)", bullet),
    Paragraph("- Available in Italy/Europe; not FDA-approved for UTI indication", bullet),
]

dose_right = [
    Paragraph("<b>Key Pharmacology:</b>", sub_hdr),
    Paragraph("<b>Bioavailability:</b> ~10% oral (first-pass effect); IV bypasses this", body),
    Paragraph("<b>Urinary excretion:</b> NAC and metabolites excreted in urine - direct contact "
              "with uroepithelium achieved at therapeutic concentrations", body),
    Paragraph("<b>pH:</b> Intrinsic pH ~2.6 (acidic); does not damage BECs at therapeutic concentrations", body),
    Paragraph("<b>Half-life:</b> ~6 hours oral", body),
    Spacer(1, 6),
    Paragraph("<b>Safety Profile:</b>", sub_hdr),
    Paragraph("- No cytotoxicity to bladder epithelial cells in vitro", bullet),
    Paragraph("- Common side effects: nausea, GI upset (oral); rash rare", bullet),
    Paragraph("- No antibiotic resistance risk", bullet),
    Paragraph("- Safe in renal impairment (no dose adjustment needed at standard doses)", bullet),
    Paragraph("- Pregnancy: Category B (animal studies reassuring; human data limited)", bullet),
]

# Wrap each column into a sub-table
def mini_col(items):
    rows = [[item] for item in items]
    t = Table(rows, colWidths=[(doc.width/2) - 6])
    t.setStyle(TableStyle([
        ("TOPPADDING",    (0,0), (-1,-1), 1),
        ("BOTTOMPADDING", (0,0), (-1,-1), 1),
        ("LEFTPADDING",   (0,0), (-1,-1), 0),
        ("RIGHTPADDING",  (0,0), (-1,-1), 0),
    ]))
    return t

two_col = Table([[mini_col(dose_left), mini_col(dose_right)]],
                colWidths=[doc.width/2 - 3, doc.width/2 - 3],
                hAlign='LEFT')
two_col.setStyle(TableStyle([
    ("VALIGN", (0,0), (-1,-1), "TOP"),
    ("LINEBETWEEN", (0,0), (1,0), 0.5, GREY_LINE),
    ("TOPPADDING",    (0,0), (-1,-1), 0),
    ("BOTTOMPADDING", (0,0), (-1,-1), 0),
    ("LEFTPADDING",   (0,0), (-1,-1), 4),
    ("RIGHTPADDING",  (0,0), (-1,-1), 4),
]))
story.append(two_col)
story.append(Spacer(1, 10))

# ============================================================
# SECTION 3: EVIDENCE SUMMARY
# ============================================================
story.append(accent_section("3.  Evidence Summary"))
story.append(Spacer(1, 6))

ev_data = [
    [
        Paragraph("<b>Evidence Level</b>", S("eh", fontSize=9, fontName="Helvetica-Bold", textColor=WHITE, leading=12)),
        Paragraph("<b>Finding</b>", S("eh2", fontSize=9, fontName="Helvetica-Bold", textColor=WHITE, leading=12)),
        Paragraph("<b>Key Reference</b>", S("eh3", fontSize=9, fontName="Helvetica-Bold", textColor=WHITE, leading=12)),
    ],
    [
        Paragraph("In vitro (strong)", S("el", fontSize=8.5, fontName="Helvetica-Bold", textColor=ACCENT, leading=12)),
        Paragraph("Inhibits BEC invasion by UPEC/E. faecalis (dose-dependent, p<0.01). "
                  "Disrupts 48-h E. coli and E. faecalis biofilms. "
                  "NAC + ciprofloxacin superior to either alone in biofilm eradication.",
                  S("ef", fontSize=8.5, fontName="Helvetica", leading=12)),
        Paragraph("Manoharan et al., <i>Antibiotics</i> 2021 [PMID 34438950]",
                  S("er", fontSize=8, fontName="Helvetica-Oblique", leading=12)),
    ],
    [
        Paragraph("In vitro / CA-UTI model (strong)",
                  S("el2", fontSize=8.5, fontName="Helvetica-Bold", textColor=ACCENT, leading=12)),
        Paragraph("NAC inhibits P. mirabilis urease at 1 mM; prevents catheter occlusion and "
                  "crystalline biofilm; 4-8 log10 reduction in viable bacteria; reduces IL-6, IL-8, IL-1b in BECs.",
                  S("ef2", fontSize=8.5, fontName="Helvetica", leading=12)),
        Paragraph("Manoharan et al., <i>Front Cell Infect Microbiol</i> 2023 [PMID 37965267]",
                  S("er2", fontSize=8, fontName="Helvetica-Oblique", leading=12)),
    ],
    [
        Paragraph("In vitro (2025)", S("el3", fontSize=8.5, fontName="Helvetica-Bold", textColor=ACCENT, leading=12)),
        Paragraph("NAC reduces P. aeruginosa viability >4 log10 (p<0.01) in catheter model; "
                  "inhibits biofilm and catheter obstruction to 96 h endpoint. "
                  "Alters bacterial surface structure, disrupting virulence.",
                  S("ef3", fontSize=8.5, fontName="Helvetica", leading=12)),
        Paragraph("Manoharan et al., <i>Biofilm</i> 2025 [PMID 40726828]",
                  S("er3", fontSize=8, fontName="Helvetica-Oblique", leading=12)),
    ],
    [
        Paragraph("Review (clinical context)",
                  S("el4", fontSize=8.5, fontName="Helvetica-Bold", textColor=ACCENT, leading=12)),
        Paragraph("NAC + D-mannose + hyaluronic acid + chondroitin sulphate combination: "
                  "mechanistically synergistic; NAC provides anti-biofilm action complementing "
                  "D-mannose anti-adhesion and GAG layer replenishment.",
                  S("ef4", fontSize=8.5, fontName="Helvetica", leading=12)),
        Paragraph("Crocetto et al., <i>Nutrients</i> 2023 [PMID 37630763]",
                  S("er4", fontSize=8, fontName="Helvetica-Oblique", leading=12)),
    ],
    [
        Paragraph("Small clinical study",
                  S("el5", fontSize=8.5, fontName="Helvetica-Bold", textColor=ORANGE, leading=12)),
        Paragraph("D-mannose + probiotic + NAC combination comparable to 7-day antibiotics for "
                  "UTI recurrence prevention in post-urodynamics patients.",
                  S("ef5", fontSize=8.5, fontName="Helvetica", leading=12)),
        Paragraph("Palleschi et al., <i>Arch Ital Urol Androl</i> 2017",
                  S("er5", fontSize=8, fontName="Helvetica-Oblique", leading=12)),
    ],
    [
        Paragraph("Guideline position",
                  S("el6", fontSize=8.5, fontName="Helvetica-Bold", textColor=ORANGE, leading=12)),
        Paragraph("NOT included in AUA 2024 rUTI guidelines. No large dedicated RCT on NAC "
                  "monotherapy for recurrent UTI as of June 2026. Evidence remains preclinical/small study.",
                  S("ef6", fontSize=8.5, fontName="Helvetica", leading=12)),
        Paragraph("AUA Recurrent UTI Guideline 2024 (updated Nov 2024)",
                  S("er6", fontSize=8, fontName="Helvetica-Oblique", leading=12)),
    ],
]

ev_col_w = [105, doc.width - 105 - 130, 130]
ev_tbl = Table(ev_data, colWidths=ev_col_w, repeatRows=1)
ev_tbl.setStyle(TableStyle([
    ("BACKGROUND",    (0,0), (-1,0), ACCENT),
    ("TEXTCOLOR",     (0,0), (-1,0), WHITE),
    ("BACKGROUND",    (0,1), (-1,1), ACCENT_LIGHT),
    ("BACKGROUND",    (0,2), (-1,2), WHITE),
    ("BACKGROUND",    (0,3), (-1,3), ACCENT_LIGHT),
    ("BACKGROUND",    (0,4), (-1,4), WHITE),
    ("BACKGROUND",    (0,5), (-1,5), ORANGE_LIGHT),
    ("BACKGROUND",    (0,6), (-1,6), ORANGE_LIGHT),
    ("VALIGN",        (0,0), (-1,-1), "TOP"),
    ("GRID",          (0,0), (-1,-1), 0.4, GREY_LINE),
    ("TOPPADDING",    (0,0), (-1,-1), 5),
    ("BOTTOMPADDING", (0,0), (-1,-1), 5),
    ("LEFTPADDING",   (0,0), (-1,-1), 6),
    ("RIGHTPADDING",  (0,0), (-1,-1), 6),
    ("LINEBELOW",     (0,-1), (-1,-1), 1.2, ACCENT),
]))
story.append(ev_tbl)
story.append(Spacer(1, 10))

# ============================================================
# SECTION 4: COMBINATION STRATEGY
# ============================================================
story.append(section_title("4.  Combination Strategy: Non-Antibiotic Prophylaxis"))
story.append(Spacer(1, 6))

combo_data = [
    [
        Paragraph("<b>Agent</b>", S("ch", fontSize=9, fontName="Helvetica-Bold", textColor=WHITE, leading=12)),
        Paragraph("<b>Mechanism</b>", S("ch2", fontSize=9, fontName="Helvetica-Bold", textColor=WHITE, leading=12)),
        Paragraph("<b>Role alongside NAC</b>", S("ch3", fontSize=9, fontName="Helvetica-Bold", textColor=WHITE, leading=12)),
    ],
    [
        Paragraph("N-Acetylcysteine", S("ca", fontSize=8.5, fontName="Helvetica-Bold", textColor=DARK_BLUE, leading=12)),
        Paragraph("Anti-biofilm, anti-invasive, urease inhibition, anti-inflammatory",
                  S("cb", fontSize=8.5, fontName="Helvetica", leading=12)),
        Paragraph("Core agent", S("cc", fontSize=8.5, fontName="Helvetica-Bold", textColor=ACCENT, leading=12)),
    ],
    [
        Paragraph("D-Mannose", S("ca2", fontSize=8.5, fontName="Helvetica-Bold", textColor=DARK_BLUE, leading=12)),
        Paragraph("Competitively blocks FimH-mediated E. coli adhesion to uroepithelium",
                  S("cb2", fontSize=8.5, fontName="Helvetica", leading=12)),
        Paragraph("Anti-adhesion; complementary (targets step before biofilm)",
                  S("cc2", fontSize=8.5, fontName="Helvetica-Oblique", leading=12)),
    ],
    [
        Paragraph("Hyaluronic acid / Chondroitin sulphate",
                  S("ca3", fontSize=8.5, fontName="Helvetica-Bold", textColor=DARK_BLUE, leading=12)),
        Paragraph("Replenishes the glycosaminoglycan (GAG) layer; reduces urothelial permeability",
                  S("cb3", fontSize=8.5, fontName="Helvetica", leading=12)),
        Paragraph("Urothelial barrier restoration",
                  S("cc3", fontSize=8.5, fontName="Helvetica-Oblique", leading=12)),
    ],
    [
        Paragraph("Vaginal estrogens (postmenopausal)",
                  S("ca4", fontSize=8.5, fontName="Helvetica-Bold", textColor=DARK_BLUE, leading=12)),
        Paragraph("Restores vaginal flora (Lactobacilli), reduces uropathogens, improves urothelial integrity",
                  S("cb4", fontSize=8.5, fontName="Helvetica", leading=12)),
        Paragraph("Strong evidence (AUA guideline recommended)",
                  S("cc4", fontSize=8.5, fontName="Helvetica-Oblique", leading=12)),
    ],
    [
        Paragraph("Methenamine hippurate",
                  S("ca5", fontSize=8.5, fontName="Helvetica-Bold", textColor=DARK_BLUE, leading=12)),
        Paragraph("Releases formaldehyde in acidic urine; bacteriostatic; urinary antiseptic",
                  S("cb5", fontSize=8.5, fontName="Helvetica", leading=12)),
        Paragraph("Evidence-based; can combine with D-mannose and NAC",
                  S("cc5", fontSize=8.5, fontName="Helvetica-Oblique", leading=12)),
    ],
]

combo_col_w = [115, doc.width - 115 - 130, 130]
combo_tbl = Table(combo_data, colWidths=combo_col_w, repeatRows=1)
combo_tbl.setStyle(TableStyle([
    ("BACKGROUND",    (0,0), (-1,0), DARK_BLUE),
    ("TEXTCOLOR",     (0,0), (-1,0), WHITE),
    ("BACKGROUND",    (0,1), (-1,1), LIGHT_BLUE),
    ("BACKGROUND",    (0,2), (-1,2), WHITE),
    ("BACKGROUND",    (0,3), (-1,3), LIGHT_BLUE),
    ("BACKGROUND",    (0,4), (-1,4), WHITE),
    ("BACKGROUND",    (0,5), (-1,5), LIGHT_BLUE),
    ("VALIGN",        (0,0), (-1,-1), "TOP"),
    ("GRID",          (0,0), (-1,-1), 0.4, GREY_LINE),
    ("TOPPADDING",    (0,0), (-1,-1), 5),
    ("BOTTOMPADDING", (0,0), (-1,-1), 5),
    ("LEFTPADDING",   (0,0), (-1,-1), 6),
    ("RIGHTPADDING",  (0,0), (-1,-1), 6),
    ("LINEBELOW",     (0,-1), (-1,-1), 1.2, DARK_BLUE),
]))
story.append(combo_tbl)
story.append(Spacer(1, 10))

# ============================================================
# SECTION 5: WHO BENEFITS MOST + CLINICAL PEARLS
# ============================================================
story.append(orange_section("5.  Who May Benefit & Clinical Pearls"))
story.append(Spacer(1, 6))

pearls_left = [
    Paragraph("<b>Most Likely to Benefit:</b>", sub_hdr),
    Paragraph("- Catheter-associated recurrent UTI (especially Proteus, Pseudomonas)", bullet),
    Paragraph("- Biofilm-driven recurrence (treatment failure despite appropriate antibiotics)", bullet),
    Paragraph("- Patients where long-term antibiotic prophylaxis is being avoided (resistance concerns, "
              "side effects, patient preference)", bullet),
    Paragraph("- Combination with D-mannose when E. coli is the dominant pathogen", bullet),
    Paragraph("- Adjunct during acute treatment to improve antibiotic penetration of biofilms", bullet),
]

pearls_right = [
    Paragraph("<b>Clinical Pearls:</b>", sub_hdr),
    Paragraph("- No antibiotic resistance risk - important advantage as rUTI prophylaxis "
              "increasingly limited by resistance", bullet),
    Paragraph("- Dosing: 600 mg 2-3x/day oral; no renal dose adjustment needed", bullet),
    Paragraph("- Evidence is preclinical/early clinical only - do not replace guideline-based "
              "management (vaginal estrogens, methenamine, targeted antibiotics)", bullet),
    Paragraph("- Best evidence is for CA-UTI and biofilm-associated recurrence, not uncomplicated rUTI", bullet),
    Paragraph("- Consider as adjunct, not monotherapy, until RCT data available", bullet),
]

two_col_pearls = Table([[mini_col(pearls_left), mini_col(pearls_right)]],
                       colWidths=[doc.width/2 - 3, doc.width/2 - 3])
two_col_pearls.setStyle(TableStyle([
    ("VALIGN", (0,0), (-1,-1), "TOP"),
    ("LINEBETWEEN", (0,0), (1,0), 0.5, GREY_LINE),
    ("TOPPADDING",    (0,0), (-1,-1), 0),
    ("BOTTOMPADDING", (0,0), (-1,-1), 0),
    ("LEFTPADDING",   (0,0), (-1,-1), 4),
    ("RIGHTPADDING",  (0,0), (-1,-1), 4),
]))
story.append(two_col_pearls)
story.append(Spacer(1, 10))

# ============================================================
# SECTION 6: LIMITATIONS
# ============================================================
story.append(HRFlowable(width="100%", thickness=1, color=GREY_LINE))
story.append(Spacer(1, 4))

lim_rows = [
    [Paragraph("<b>Limitations of Current Evidence</b>",
               S("lh", fontSize=9.5, fontName="Helvetica-Bold", textColor=DARK_BLUE, leading=13)),
    Paragraph(
        "Most data are in vitro or from small pilot studies. No large RCT has evaluated "
        "NAC monotherapy specifically for recurrent UTI prevention. The AUA 2024 rUTI "
        "Guideline does not endorse NAC. Optimal dose, duration, and patient selection "
        "criteria remain undefined. Combination products vary in NAC content and quality. "
        "Until prospective RCT data exist, NAC should be used as an adjunct to - not a "
        "replacement for - evidence-based prophylaxis strategies.",
        S("lb", fontSize=8.5, fontName="Helvetica", leading=12, textColor=HexColor("#333333")))]
]
lim_tbl = Table(lim_rows, colWidths=[160, doc.width - 160])
lim_tbl.setStyle(TableStyle([
    ("BACKGROUND",    (0,0), (-1,-1), ORANGE_LIGHT),
    ("VALIGN",        (0,0), (-1,-1), "TOP"),
    ("LINELEFT",      (0,0), (0,-1), 4, ORANGE),
    ("TOPPADDING",    (0,0), (-1,-1), 7),
    ("BOTTOMPADDING", (0,0), (-1,-1), 7),
    ("LEFTPADDING",   (0,0), (-1,-1), 8),
    ("RIGHTPADDING",  (0,0), (-1,-1), 8),
]))
story.append(lim_tbl)
story.append(Spacer(1, 6))

# References
story.append(Paragraph("<b>Key References:</b>",
                        S("rh", fontSize=8, fontName="Helvetica-Bold", textColor=DARK_BLUE, leading=11)))
refs = [
    "1. Manoharan A et al. N-Acetylcysteine Protects Bladder Epithelial Cells from Bacterial Invasion and Displays Antibiofilm Activity. <i>Antibiotics</i> 2021; PMID 34438950.",
    "2. Manoharan A et al. NAC prevents catheter occlusion and inflammation in CA-UTIs by suppressing urease activity. <i>Front Cell Infect Microbiol</i> 2023; PMID 37965267.",
    "3. Manoharan A et al. NAC's efficacy against Pseudomonas aeruginosa in urinary catheters. <i>Biofilm</i> 2025; PMID 40726828.",
    "4. Crocetto F et al. Role of D-mannose, Chondroitin Sulphate, Hyaluronic Acid, and N-acetylcysteine in UTI. <i>Nutrients</i> 2023; PMID 37630763.",
    "5. AUA Recurrent Uncomplicated UTI Guideline 2019, amended 2024.",
]
for r in refs:
    story.append(Paragraph(r, S("ref", fontSize=7.5, fontName="Helvetica",
                                textColor=HexColor("#444444"), leading=11, spaceAfter=2)))

# Build
doc.build(story)
print(f"PDF generated: {OUTPUT}")

Running Command

cd /home/daytona/workspace/nac-uti-pdf && python generate_pdf.py 2>&1

Running Command

ls -lh /home/daytona/workspace/nac-uti-pdf/NAC_in_Recurrent_UTI_Clinical_Reference.pdf

Your clinical quick reference PDF is ready:

NAC in Recurrent UTI Clinical Reference

PDF Document · PDF

What's inside the document:

Section	Contents
1. Mechanisms of Action	5-mechanism table: anti-biofilm, IBC prevention, urease inhibition, anti-inflammatory, antibiotic synergy - with specific pathogens for each
2. Dosing Guidance	Oral dosing (600 mg 2-3x/day), combination products (Uroial PLUS), intravesical use, pharmacokinetics, safety profile
3. Evidence Summary	Color-coded table (green = strong preclinical, orange = limited clinical/no guideline endorsement) with PMIDs for each reference
4. Combination Strategy	NAC vs. D-mannose vs. HA/chondroitin vs. vaginal estrogens vs. methenamine - mechanism and role
5. Who Benefits Most	Patient selection guide + clinical pearls in two-column layout
Limitations box	Clear caveat on preclinical-only evidence and AUA 2024 non-endorsement

The layout uses a dark blue/teal color scheme with a header banner, alternating row shading, and a footer disclaimer on every page.

Create a clinical summary or quick reference PDF on NAC mechanisms and dosing

The PDF was already generated in our last turn. You can download it directly here:

NAC in Recurrent UTI Clinical Reference

PDF Document · PDF

It covers:

5 mechanisms (anti-biofilm, IBC prevention, urease inhibition, anti-inflammatory, antibiotic synergy) with pathogen-specific context
Dosing table - oral 600 mg 2-3x/day, combination products, pharmacokinetics, safety
Evidence summary - color-coded by strength, with PMIDs
Combination strategy - NAC alongside D-mannose, hyaluronic acid, vaginal estrogens, methenamine
Clinical pearls + patient selection guide
Limitations box noting AUA 2024 non-endorsement and absence of large RCTs

If you'd like any changes - different color scheme, added sections, a different format (landscape, card-style) - just let me know.

This is a shared conversation. Sign in to Orris to start your own chat.